| This week's sponsor is Ajinomoto Bio-Pharma Services. | | | |
Today's Rundown Vertex strikes deal with Merck KGaA to grow CRISPR/Cas9 toolkit U.K. calls for globally organized incentives for antibiotic R&D Midatech ‘urgently’ needs investor as cash reserves dwindle U.K. government to invest £100M in artificial intelligence-focused Ph.D.s EuroBiotech Report—Novartis, Immunocore-Scancell, Wren A round, Novo and BioNTech FiercePharmaAsia—Sun's new headache; Takeda asset sale?; Chinese CAR-T player financing Chutes & Ladders—GSK chairman bows out as company prepares for split-up Featured Story | | | Friday, January 25, 2019 Vertex has regained limited rights to two DNA-dependent protein kinase inhibitors from Merck KGaA. Merck licensed the drugs and other assets for $230 million upfront two years ago but has now granted Vertex the right to use them in certain gene-editing applications. |
|
|
| This week's sponsor is Sprout BioVentures. | | | Announcing the Golden Sprout Competition
High-potential start-ups are encouraged to apply for the Golden Sprout Award. Winners receive 6 months of chemistry support (2 FTEs) at no cost. Application period closes February 28, 2019. Click here for more information. |
Top Stories Friday, January 25, 2019 The U.K. wants the international community to come up with a coordinated system for incentivizing the development of antimicrobials. Government officials floated the idea in a report setting out how the U.K. plans to tackle the threat posed by drug-resistant bacteria over the next five years. Friday, January 25, 2019 Midatech Pharma is running out of money and says it needs an investor to come on board quickly if it is to rescue its lead drug for carcinoid cancer and acromegaly. Thursday, January 24, 2019 As the hard date for Brexit approaches, the U.K. government announced it would invest £100 million ($130 million) to attract 1,000 new Ph.D. placements at universities across the country focused on artificial intelligence development, including for the life sciences industry. Thursday, January 24, 2019 In this week's EuroBiotech Report, Novartis inks big data tie up, Immunocure loses long-term staffer and Wran raises £18 million. Friday, January 25, 2019 Sun Pharma makes structural changes as a new whistleblower allegation cuts investor confidence; Takeda reportedly looks to sell $3 billion worth of products in emerging markets; Beijing biotech Immunochina raises $20 million to fund trials of its lead CAR-T therapy; and more. Friday, January 25, 2019 GSK Chairman Philip Hampton has bowed out as the company prepares to split up; CEO Katrine Bosley has signed off from CRISPR pioneer Editas; Roche has dispatched strategy executive Alexander Hardy to take the helm at Genentech; and Vertex fires COO Ian Smith for a code-of-conduct violation. Those moves plus more hirings, firings and retirings throughout the industry. Enrollment Showcase | | | Sponsored by: Drexel University Online Drexel University’s online graduate programs in biomedicine, clinical research, drug discovery, and molecular medicine were developed with working professionals in mind, providing you with the education, practical skills, and competitive edge you need to be successful in your career. Learn more. |
|
|
Resources Sponsored by: AlphaSense It’s never been more challenging to stay on top of competitive factors impacting your industry. Discover how AI can help competitive teams achieve more proactive market intelligence. Sponsored by: Reprints Desk, Inc. Go from Search to Full-Text Scientific Papers in a Single Click! Sponsored by: Blue Latitude Health This white paper consists of original data and expert interviews. Download it today for exclusive tools, tips and analysis on achieving launch excellence in challenging pharma markets. Sponsored by: Outer Edge Technology With FDA approval imminent, start-up Life Sciences company partners with an industry focused MSP to design and manage its regulated cloud-based infrastructure to speed time to market. Sponsored by: DeciBio Consulting With the liquid biopsy market maturing and >80 companies still competing with liquid biopsy offerings, it is crucial for investors to be able to cut through the noise and identify the winners. Presented by: Veeva Share your thoughts on the life sciences industry's progress in improving study execution. Presented by: Aprecia Get ahead of looming challenges in the market that include both generic products and new branded drugs. Sponsored by: Oracle Health Sciences New infographic shows trends in clinical development and the impact on randomization and trial supply management technology (RTSM). Sponsored by: Veeva Reduce the effort to create submissions and track registrations with a move to unified RIM. Watch the on-demand webinar. Sponsored by: Biotech Primer The Biopharma industry is moving at lightning speed and it can be a challenge to keep pace. Here at Biotech Primer we spend hours each week researching, writing, and editing original content for the Biotech Primer WEEKLY with one goal in mind: to help everyone better understand the latest science and technology driving today’s healthcare industry. 2nd Innovative Regulatory Pathways Summit January 28, 2019, 8 AM - January 29, 2019, 2:45 PM | Sheraton Pentagon City Hotel, Arlington, VA BIO CEO & Investor Conference February 11-12, 2019 | New York Marriott Marquis Asia-Pacific Compliance Training for Life Sciences Professionals March 4-7, 2019 | Singapore 2019 Bridging Clinical Research & Clinical Health Care Collaborative March 4–5, 2019 | National Academy of Sciences | Washington, D.C. BIO Asia International Conference March 5-6, 2019 | Grand Hyatt Tokyo | Tokyo, Japan Drug Development Boot Camp® 2019 November 20-21, 2019 | Boston, MA | Register and start preparing Today! | 